Lemirise DS HIV/ARV Products Manufacturer in India

 Lemirise DS HIV/ARV Products are pharmaceutical products containing a combination of Lamivudine 60mg and Stavudine 12mg. These active pharmaceutical ingredients belong to the antiretroviral medicine category and have been used in combination antiretroviral therapy for the management of HIV infection. Sunrise Remedies is engaged in the manufacturing and supply of pharmaceutical products, including HIV/ARV product ranges, for healthcare markets.

As demand for pharmaceutical products continues to grow across international markets, manufacturers and suppliers play an important role in supporting healthcare distribution networks. Lemirise DS is formulated with two antiretroviral active ingredients, Lamivudine and Stavudine, providing a combination product intended for use under appropriate medical supervision.

What Are Lemirise DS HIV/ARV Products?

Lemirise DS HIV/ARV Products contain:

• Lamivudine 60mg

• Stavudine 12mg

Lamivudine is a nucleoside reverse transcriptase inhibitor (NRTI), while Stavudine is also classified as a nucleoside reverse transcriptase inhibitor. Antiretroviral medicines work by interfering with HIV replication. HIV treatment generally involves a combination of antiretroviral medicines selected according to the patient's clinical condition, treatment history, applicable guidelines, and healthcare professional's assessment.

The specific formulation, dosage, and suitability of Lemirise DS should always be determined by a qualified healthcare professional. Patients should not start, stop, or modify HIV treatment without medical advice.

Lamivudine 60mg and Stavudine 12mg Combination

The combination of Lamivudine 60mg and Stavudine 12mg brings together two NRTI-class antiretroviral agents. Both medicines act on the reverse transcriptase enzyme involved in HIV replication.

Lamivudine is converted inside cells into its active form and interferes with the viral reverse transcriptase process. Stavudine also undergoes intracellular activation and inhibits HIV reverse transcriptase. By targeting viral replication through related mechanisms, these medicines have historically been used as part of combination antiretroviral treatment.

The use of particular antiretroviral combinations depends on current treatment guidelines and individual patient factors. Healthcare professionals consider factors such as previous treatment, resistance patterns, drug interactions, tolerability, and other clinical considerations when selecting therapy.

Importance of HIV/ARV Medicines

HIV is a chronic viral infection that requires appropriate long-term medical management. Antiretroviral therapy has significantly improved HIV care by helping control viral replication and supporting immune-system function.

Effective HIV treatment generally involves a combination of antiretroviral medicines rather than relying on a single medicine. Maintaining the prescribed treatment schedule is important because inconsistent use can affect treatment effectiveness and may contribute to the development of drug resistance.

Products within the HIV/ARV category therefore require appropriate manufacturing, quality management, packaging, storage, distribution, and regulatory compliance. Pharmaceutical manufacturers and suppliers have an important role in ensuring that products reach healthcare providers and authorized distribution channels according to applicable requirements.

Lemirise DS HIV/ARV Products Manufacturer in India

India has an established pharmaceutical manufacturing sector serving both domestic and international healthcare markets. Sunrise Remedies offers pharmaceutical products across different therapeutic categories and includes HIV/ARV products within its product portfolio.

As a Lemirise DS HIV/ARV Products Manufacturer in India, Sunrise Remedies focuses on pharmaceutical manufacturing and supply requirements while supporting business-to-business healthcare distribution. The company works with pharmaceutical businesses, distributors, and other authorized healthcare-sector partners according to applicable commercial and regulatory requirements.

For organizations looking to source Lemirise DS products, product specifications, packaging options, documentation, availability, and export requirements can be discussed directly with the company.

Product Information at a Glance

Products	Active Ingredients
Lemirise DS HIV/ARV Products	Lamivudine 60mg + Stavudine 12mg
Therapeutic Category	Antiretroviral
Drug Classes	NRTIs
Intended Use	HIV treatment as directed by a healthcare professional

The above information is provided for general product awareness. It does not replace prescribing information, professional medical advice, or local treatment guidelines.

Manufacturing and Quality Considerations

Quality is an important consideration for pharmaceutical products, particularly antiretroviral medicines intended for long-term treatment programs. Pharmaceutical manufacturing involves multiple stages, including sourcing of raw materials, formulation, processing, quality testing, packaging, storage, and distribution.

A pharmaceutical manufacturer must maintain appropriate quality systems throughout the production process. Testing and documentation help ensure that products meet their applicable specifications before release.

For buyers and distributors, important product-related information may include composition, dosage strength, pack size, manufacturing details, shelf life, storage conditions, batch information, and regulatory documentation. Requirements can differ between countries, so importers should verify the applicable regulatory and registration requirements in their destination market.

Applications of Lemirise DS HIV/ARV Products

Lemirise DS contains two antiretroviral active ingredients and is associated with HIV treatment under medical supervision. Its use should be based on an appropriate clinical assessment and the treatment recommendations of a qualified healthcare professional.

HIV treatment is individualized. A healthcare professional may consider several factors before selecting or changing an antiretroviral regimen. These may include:

• Patient age and clinical status

• Previous antiretroviral treatment

• Possible drug resistance

• Other medicines being taken

• Potential drug interactions

• Kidney and liver considerations

• Current treatment guidelines

• Individual tolerability and safety considerations

Because of these factors, the presence of Lamivudine and Stavudine in a product does not mean that the product is appropriate for every patient.

Storage and Handling

Pharmaceutical products should be stored and handled according to the manufacturer's approved product information and packaging instructions. Appropriate storage helps maintain product quality throughout its shelf life.

Distributors and healthcare organizations should pay attention to storage conditions, transportation requirements, inventory rotation, packaging integrity, and batch traceability. Products should remain within authorized pharmaceutical supply chains and should be purchased from appropriate sources.

Patients should also keep medicines in their original packaging and follow the storage instructions provided with the product.

Why Choose a Pharmaceutical Manufacturer in India?

India's pharmaceutical industry serves a broad network of healthcare companies, distributors, exporters, and institutional buyers. Manufacturers based in India can support pharmaceutical supply requirements across different markets while working within applicable manufacturing and regulatory frameworks.

For companies sourcing HIV/ARV products, important considerations include product composition, manufacturing capabilities, quality systems, documentation, packaging requirements, supply capacity, and regulatory support.

Sunrise Remedies provides access to pharmaceutical products and works with healthcare-sector businesses seeking manufacturing and supply solutions. Organizations interested in Lemirise DS HIV/ARV Products can contact the company to discuss product and business requirements.

Responsible Use of Antiretroviral Products

Antiretroviral medicines must be used responsibly. Patients should follow the treatment plan provided by their healthcare professional and attend recommended follow-up appointments.

Do not discontinue or change HIV medicines without consulting a healthcare professional. Different antiretroviral medicines can have specific precautions, interactions, and adverse effects. Medical professionals can assess the benefits and risks of a particular treatment regimen and provide appropriate monitoring.

This article is intended for general pharmaceutical and product information. It is not a substitute for medical diagnosis, prescription, or treatment advice.

Sunrise Remedies: Lemirise DS HIV/ARV Products

Sunrise Remedies provides pharmaceutical manufacturing and supply solutions for healthcare businesses and international markets. The company's HIV/ARV product portfolio includes products formulated with different antiretroviral ingredients and strengths.

For Lemirise DS HIV/ARV Products, the stated composition is Lamivudine 60mg and Stavudine 12mg. Businesses interested in product availability, packaging, commercial requirements, documentation, or supply opportunities can contact Sunrise Remedies directly.

Conclusion

Lemirise DS HIV/ARV Products contain Lamivudine 60mg and Stavudine 12mg, two NRTI-class antiretroviral ingredients. Appropriate manufacturing, quality management, documentation, storage, and distribution are important factors in maintaining pharmaceutical product quality.

Sunrise Remedies supports pharmaceutical manufacturing and supply requirements and offers HIV/ARV products for healthcare-sector businesses. For product specifications, availability, packaging, and supply inquiries related to Lemirise DS, interested businesses can contact Sunrise Remedies directly using the contact details .

Contact Sunrise Remedies

Phone: +91 7575043215

Email: info@sunriseremedies.in

Website: sunriseremedies.in